There is also evidence that tumor growth is associated with somatic mutation in the Keap1-Nrf2 system, disrupting the interaction between Nrf2 and Keap1, which finally leads to constitutive stabilization and activation of Nrf2 [60,61]. The gene discussed is KEAP1; the disease is neoplasm.